These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31982428)
1. LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis. Xu Y; Luo Y; Liang C; Zhang T J Mol Cell Cardiol; 2020 Feb; 139():47-61. PubMed ID: 31982428 [TBL] [Abstract][Full Text] [Related]
2. The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin. Luo Y; Xu Y; Liang C; Xing W; Zhang T Cell Signal; 2018 Mar; 43():11-20. PubMed ID: 29199045 [TBL] [Abstract][Full Text] [Related]
3. MiR-466h-5p induces expression of myocardin with complementary promoter sequences. Luo Y; Liang C; Xu Y; Zhang T Biochem Biophys Res Commun; 2019 Jun; 514(1):187-193. PubMed ID: 31029421 [TBL] [Abstract][Full Text] [Related]
4. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. Yoshida T; Yamashita M; Horimai C; Hayashi M J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730 [TBL] [Abstract][Full Text] [Related]
5. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. Wang K; Long B; Zhou J; Li PF J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053 [TBL] [Abstract][Full Text] [Related]
6. Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy. Xu Y; Liang C; Luo Y; Xing W; Zhang T J Cell Biochem; 2019 Jun; 120(6):9047-9055. PubMed ID: 30582211 [TBL] [Abstract][Full Text] [Related]
7. A long noncoding RNA protects the heart from pathological hypertrophy. Han P; Li W; Lin CH; Yang J; Shang C; Nuernberg ST; Jin KK; Xu W; Lin CY; Lin CJ; Xiong Y; Chien H; Zhou B; Ashley E; Bernstein D; Chen PS; Chen HV; Quertermous T; Chang CP Nature; 2014 Oct; 514(7520):102-106. PubMed ID: 25119045 [TBL] [Abstract][Full Text] [Related]
8. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844 [TBL] [Abstract][Full Text] [Related]
9. SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy. Liu MY; Yue LJ; Luo YC; Lu J; Wu GD; Sheng SQ; Shi YQ; Dong ZX Eur J Pharmacol; 2022 Sep; 930():175155. PubMed ID: 35863508 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of lncRNA VDR/CASC15 induced by facilitates cardiac hypertrophy through modulating miR-432-5p/TLR4 axis. Li C; Zhou G; Feng J; Zhang J; Hou L; Cheng Z Biochem Biophys Res Commun; 2018 Sep; 503(4):2407-2414. PubMed ID: 29966657 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93. Wo Y; Guo J; Li P; Yang H; Wo J Cardiovasc Pathol; 2018; 35():29-36. PubMed ID: 29747050 [TBL] [Abstract][Full Text] [Related]
12. STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis. Zhang J; Liang Y; Huang X; Guo X; Liu Y; Zhong J; Yuan J Sci Rep; 2019 Jan; 9(1):460. PubMed ID: 30679521 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling. Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866 [TBL] [Abstract][Full Text] [Related]
15. SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17. Long Y; Wang L; Li Z J Cell Mol Med; 2020 Jul; 24(13):7115-7126. PubMed ID: 32436661 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice. Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312 [TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880 [TBL] [Abstract][Full Text] [Related]
18. LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a/DKK1/Wnt-β-catenin signalling. Fang Q; Liu T; Yu C; Yang X; Shao Y; Shi J; Ye X; Zheng X; Yan J; Xu D; Zou X J Cell Mol Med; 2020 Mar; 24(6):3678-3691. PubMed ID: 32057178 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes. Chiu CZ; Wang BW; Chung TH; Shyu KG Clin Sci (Lond); 2010 Jun; 119(7):273-82. PubMed ID: 20446923 [TBL] [Abstract][Full Text] [Related]
20. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Liu CY; Zhang YH; Li RB; Zhou LY; An T; Zhang RC; Zhai M; Huang Y; Yan KW; Dong YH; Ponnusamy M; Shan C; Xu S; Wang Q; Zhang YH; Zhang J; Wang K Nat Commun; 2018 Jan; 9(1):29. PubMed ID: 29295976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]